Mark Kirschbaum's Net Worth
$74 Thousand
Who is Mark Kirschbaum?
Mark Kirschbaum does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Cyclacel Pharmaceuticals, Inc..
SEC CIK
Mark Kirschbaum's CIK is 0001830211
Past Insider Trading and Trends
2023 was Mark Kirschbaum's most active year for acquiring shares with 2 total transactions. Mark Kirschbaum's most active month to acquire stocks was the month of December. 2020 saw Mark Kirschbaum paying a total of $0.00 for 120,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $2.3718
Chief Medical OfficerMark Kirschbaum owns 31,200 units of Common Stock which is worth $74,000.16. From 2020 to 2023 Mark Kirschbaum acquired a total of 31,200 shares in Cyclacel Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
∞
| 31.2K |
—
|
—
| 31.2K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||